From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

Bioinformatics Resource Centers for Infectious Diseases Viral Project

by Global Biodefense Staff
November 12, 2014

Scientists from the J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, are key members of a team recently awarded up to a 5-year, $23 million contract by the National Institute of Allergy and Infectious Diseases (NIAID) for the Bioinformatics Resource Centers (BRC) for Infectious Diseases Viral Project.

The JCVI-Northrop Grumman Systems Corporation-Vecna Team continues as lead organizations on this renewal of the team’s BRC project that began in 2004, and will continue to develop and augment the Influenza Research Database (IRD) and the Virus Pathogen Resource. Richard Scheuermann, Ph.D., JCVI’s Director of Informatics, is the Principal Investigator on this award.

IRD and ViPR are comprehensive human pathogenic virus databases, along with the computational and visualization tools, that enable scientists worldwide to conduct research into the control and eventual elimination of these pathogens.

The list of pathogenic viruses contained in these public databases includes:

  • Influenza
  • Ebola
  • Dengue
  • SARS/MERS
  • Hepatitis C
  • Chikungunya
  • Enterovirus D68

The IRD/ViPR websites each week attract more than 2,000 unique users from 170 countries. Research compiled from these sites has contributed to more than 270 scientific publications.

“We are very pleased to continue our work on this important NIAID project. The Viral Bioinformatics Resource Center project complements the strengths in viral genomics, pathogenesis and vaccine production at JCVI and is an essential aid to researchers tackling the new and emerging biological threats the world faces today,” said Scheuermann.

This project is fully funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health & Human Services.

Source: JCVI press release, adapted.

From Our Partners
Tags: AwardsBioinformaticsChikungunyaEbolaEnterovirus D68InfluenzaMERS-CoV

Related Posts

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America
Infectious Diseases

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America

June 10, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Pathogens

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC